Publicaciones en colaboración con investigadores/as de Hospital Universitario Central de Asturias (34)

2024

  1. Signaling, cancer cell plasticity, and intratumor heterogeneity

    Cell Communication and Signaling

  2. Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies

    Cell Communication and Signaling, Vol. 22, Núm. 1

2023

  1. Cumulative Genetic Score and C9orf72 Repeat Status Independently Contribute to Amyotrophic Lateral Sclerosis Risk in 2 Case-Control Studies

    Neurology: Genetics, Vol. 9, Núm. 4

2022

  1. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

  2. Unraveling the Diagnosis of Kiwifruit Allergy: Usefulness of Current Diagnostic Tests

    Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 3, pp. 206-212

2021

  1. A novel circulating microRNA for the detection of acute myocarditis

    New England Journal of Medicine, Vol. 384, Núm. 21, pp. 2014-2027

  2. Dna methylomes and epigenetic age acceleration associations with poor metabolic control in t1d

    Biomedicines, Vol. 9, Núm. 1, pp. 1-8

  3. Epigenetic Deregulation of the Histone Methyltransferase KMT5B Contributes to Malignant Transformation in Glioblastoma

    Frontiers in Cell and Developmental Biology, Vol. 9

  4. Integrative methylome-transcriptome analysis unravels cancer cell vulnerabilities in infant MLLrearranged B cell acute lymphoblastic leukemia

    Journal of Clinical Investigation, Vol. 131, Núm. 13

2020

  1. Chronic lymphocytic leukemia patients with IGH translocations are characterized by a distinct genetic landscape with prognostic implications

    International Journal of Cancer, Vol. 147, Núm. 10, pp. 2780-2792

  2. Epigenetic downregulation of TET3 reduces genome-wide 5hmC levels and promotes glioblastoma tumorigenesis

    International Journal of Cancer, Vol. 146, Núm. 2, pp. 373-387

  3. Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers

    Cell, Vol. 182, Núm. 4, pp. 1044-1061.e18

  4. No genome-wide DNA methylation changes found associated with medium-term reduced graphene oxide exposure in human lung epithelial cells

    Epigenetics, Vol. 15, Núm. 3, pp. 283-293

2019

  1. Chromatin regulation by Histone H4 acetylation at Lysine 16 during cell death and differentiation in the myeloid compartment

    Nucleic Acids Research, Vol. 47, Núm. 10, pp. 5016-5037

  2. Epigenetics and Lifestyle: The Impact of Stress, Diet, and Social Habits on Tissue Homeostasis

    Epigenetics and Regeneration (Elsevier), pp. 461-489

  3. Longitudinal genome-wide DNA methylation analysis uncovers persistent early-life DNA methylation changes

    Journal of Translational Medicine, Vol. 17, Núm. 1

2018

  1. Characterizing patients with multiple chromosomal aberrations detected by FISH in chronic lymphocytic leukemia

    Leukemia and Lymphoma, Vol. 59, Núm. 3, pp. 633-642

  2. Distinct chromatin signatures of DNA hypomethylation in aging and cancer

    Aging Cell, Vol. 17, Núm. 3

  3. Epigenetic dysregulation of TET2 in human glioblastoma

    Oncotarget, Vol. 9, Núm. 40, pp. 25922-25934

  4. SDHC promoter methylation, a novel pathogenic mechanism in parasympathetic paragangliomas

    Journal of Clinical Endocrinology and Metabolism, Vol. 103, Núm. 1, pp. 295-305